Published in J Cell Sci on June 01, 1993
Pathogenesis of cerebral malaria: recent experimental data and possible applications for humans. Clin Microbiol Rev (2001) 1.91
Platelets potentiate brain endothelial alterations induced by Plasmodium falciparum. Infect Immun (2006) 1.51
Increased MAPK activation and impaired insulin signaling in subcutaneous microvascular endothelial cells in type 2 diabetes: the role of endothelin-1. Diabetes (2009) 1.11
Ultrastructural evidence for blood microvessels devoid of an endothelial cell lining in transplanted pancreatic islets. Am J Pathol (1995) 1.01
Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis. Arthritis Res Ther (2011) 0.94
Sheep lung cytochrome P4501A1 (CYP1A1): cDNA cloning and transcriptional regulation by oxygen tension. J Clin Invest (1995) 0.89
Biocompatibility of cerium dioxide and silicon dioxide nanoparticles with endothelial cells. Beilstein J Nanotechnol (2014) 0.81
Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis. Arthritis Res Ther (2015) 0.77
Experimental Models of Microvascular Immunopathology: The Example of Cerebral Malaria. J Neuroinfect Dis (2014) 0.76
Enolase of Streptococcus Suis Serotype 2 Enhances Blood-Brain Barrier Permeability by Inducing IL-8 Release. Inflammation (2016) 0.76
Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells. Arthritis Res Ther (2017) 0.75
Proceedings of the Annual Symposium on Regenerative Medicine(PASRM). J Stem Cells Regen Med (2010) 0.75
A Methodology for Concomitant Isolation of Intimal and Adventitial Endothelial Cells from the Human Thoracic Aorta. PLoS One (2015) 0.75
Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest (1997) 3.39
The production and molecular properties of the zinc beta-lactamase of Pseudomonas maltophilia IID 1275. Biochem J (1985) 2.48
Delta4, an endothelial specific notch ligand expressed at sites of physiological and tumor angiogenesis. Differentiation (2001) 2.46
Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells. J Natl Cancer Inst (1995) 2.07
Hypoxia and oxidative stress in breast cancer. Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer. Breast Cancer Res (2001) 1.97
Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen. Cancer Res (2000) 1.88
Differential expression of human Wnt genes 2, 3, 4, and 7B in human breast cell lines and normal and disease states of human breast tissue. Cancer Res (1994) 1.72
An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis. Cancer Res (1997) 1.63
Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer. Cancer Res (1993) 1.58
The pH-dependence of class B and class C beta-lactamases. Biochem J (1983) 1.58
Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc Natl Acad Sci U S A (1995) 1.54
Cryoenzymology of Bacillus cereus beta-lactamase II. Biochemistry (1985) 1.50
Heterogeneity of vascular endothelial cells with relevance to diagnosis of vascular tumours. J Clin Pathol (1992) 1.48
Expression of platelet-derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine phosphorylase activity. Biochemistry (1992) 1.47
Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: an immunohistochemical study. J Pathol (1995) 1.45
In silico cloning of novel endothelial-specific genes. Genome Res (2000) 1.42
Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res (1995) 1.39
Inhibition of colon and breast carcinoma cell growth by interleukin-4. Cancer Res (1992) 1.34
The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium. Br J Cancer (1996) 1.33
The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo. Br J Cancer (2000) 1.33
Thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis. Biochem J (1998) 1.32
The angiogenic factor midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancers. Cancer Res (1996) 1.31
The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast tumor cells grown in vitro and in vivo. Cancer Res (1997) 1.31
Urinary vascular endothelial growth factor and its correlation with bladder cancer recurrence rates. J Urol (1999) 1.30
Increased sensitivity to the prodrug 5'-deoxy-5-fluorouridine and modulation of 5-fluoro-2'-deoxyuridine sensitivity in MCF-7 cells transfected with thymidine phosphorylase. Br J Cancer (1995) 1.30
Adrenomedullin and tumour angiogenesis. Br J Cancer (2006) 1.27
Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer. Cancer Res (1997) 1.24
Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors. Cancer Res (2000) 1.22
Validation of anti-vascular endothelial growth factor (anti-VEGF) antibodies for immunohistochemical localization of VEGF in tissue sections: expression of VEGF in the human endometrium. J Pathol (1998) 1.17
The isolation and long-term culture of normal human endometrial epithelium and stroma. Expression of mRNAs for angiogenic polypeptides basally and on oestrogen and progesterone challenges. J Cell Sci (1995) 1.17
Differential expression of vascular endothelial growth factor mRNA vs protein isoform expression in human breast cancer and relationship to eIF-4E. Br J Cancer (1998) 1.16
Changes in the coordination geometry of the active-site metal during catalysis of benzylpenicillin hydrolysis by Bacillus cereus beta-lactamase II. Biochemistry (1986) 1.15
Expression of VEGF in routinely fixed material using a new monoclonal antibody VG1. J Pathol (1998) 1.15
PCR display identifies tamoxifen induction of the novel angiogenic factor adrenomedullin by a non estrogenic mechanism in the human endometrium. Oncogene (1998) 1.14
Single-turnover and steady-state kinetics of hydrolysis of cephalosporins by beta-lactamase I from Bacillus cereus. Biochem J (1985) 1.13
Expression and hormone regulation of Wnt2, 3, 4, 5a, 7a, 7b and 10b in normal human endometrium and endometrial carcinoma. Br J Cancer (1997) 1.13
Association of ovarian malignancy with expression of platelet-derived endothelial cell growth factor. J Natl Cancer Inst (1994) 1.13
Identification and angiogenic role of the novel tumor endothelial marker CLEC14A. Oncogene (2011) 1.11
Eukaryotic initiation factor-4E in superficial and muscle invasive bladder cancer and its correlation with vascular endothelial growth factor expression and tumour progression. Br J Cancer (2000) 1.10
Interleukin-4 is a potent mitogen for capillary endothelium. Biochem Biophys Res Commun (1991) 1.10
Inhibition of vascular endothelial cell growth by activin-A. J Biol Chem (1993) 1.09
Expression of adhesion molecules on the endothelium of normal tissue vessels and vascular tumors. Lab Invest (1993) 1.08
Angiogenesis in psoriasis. Angiogenesis (2002) 1.08
Adrenomedullin inhibits hypoxic cell death by upregulation of Bcl-2 in endometrial cancer cells: a possible promotion mechanism for tumour growth. Oncogene (2001) 1.07
Suppression of luteal angiogenesis in the primate after neutralization of vascular endothelial growth factor. Endocrinology (2000) 1.06
Modulation of mitogenic stimuli by angiogenin correlates with in vitro phosphatidylinositol bisphosphate synthesis. Proc Natl Acad Sci U S A (1989) 1.05
Expression of angiogenic factor thymidine phosphorylase and angiogenesis in human atherosclerosis. J Pathol (2000) 1.04
The promise of anti-angiogenic cancer therapy. Br J Cancer (2000) 1.03
Heterogeneity of the endothelial cell and its role in organ preference of tumour metastasis. Trends Pharmacol Sci (1991) 1.01
Expression of the angiogenic factor thymidine phosphorylase/platelet-derived endothelial cell growth factor in primary bladder cancers. Cancer Res (1996) 1.01
Tumor stroma as a target in cancer. Curr Cancer Drug Targets (2008) 1.01
Controlling the vasculature: angiogenesis, anti-angiogenesis and vascular targeting of gene therapy. Trends Pharmacol Sci (1995) 1.00
Elevated serum vascular endothelial growth factor in patients with hormone-escaped prostate cancer. BJU Int (2000) 0.98
Regulation of Wnt5a mRNA expression in human mammary epithelial cells by cell shape, confluence, and hepatocyte growth factor. J Biol Chem (1995) 0.98
Role of the hypoxia sensing system, acidity and reproductive hormones in the variability of vascular endothelial growth factor induction in human breast carcinoma cell lines. Int J Cancer (1998) 0.96
Increasing endothelial cell specific expression by the use of heterologous hypoxic and cytokine-inducible enhancers. Gene Ther (2000) 0.96
Adrenomedullin is an autocrine regulator of endothelial growth in human endometrium. Mol Hum Reprod (2000) 0.94
Gene therapy through signal transduction pathways and angiogenic growth factors as therapeutic targets in breast cancer. Cancer (1994) 0.94
Antibody for detecting p53 protein by immunohistochemistry in normal tissues. J Clin Pathol (1994) 0.94
Endothelial cell-specific expression of tumor necrosis factor-alpha from the KDR or E-selectin promoters following retroviral delivery. Hum Gene Ther (1997) 0.93
Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in human bladder tumors and cell lines. Clin Cancer Res (2001) 0.93
New molecular pathways in angiogenesis. Br J Cancer (2003) 0.91
Human bladder cancer invasion model using rat bladder in vitro and its use to test mechanisms and therapeutic inhibitors of invasion. Br J Cancer (2001) 0.91
Differential and cell-specific expression of calcitonin receptor-like receptor and receptor activity modifying proteins in the human uterus. Mol Hum Reprod (2001) 0.91
Responses of pertussis toxin-treated microvascular endothelial cells to transforming growth factor beta 1. No evidence for pertussis-sensitive G-protein involvement in TGF-beta signal transduction. J Biol Chem (1992) 0.90
In-vivo angiogenesis and progestogens. Hum Reprod (2002) 0.89
Tissue and plasma expression of the angiogenic peptide adrenomedullin in breast cancer. Br J Cancer (2003) 0.88
Thymidine phosphorylase expression in endometrial carcinomas. Clin Exp Metastasis (1999) 0.88
Regulation of the expression of the angiogenic enzyme platelet-derived endothelial cell growth factor/thymidine phosphorylase in endometrial isolates by ovarian steroids and cytokines. Endocrinology (1997) 0.87
Expression of the hypoxically regulated angiogenic factor adrenomedullin correlates with uterine leiomyoma vascular density. Clin Cancer Res (2000) 0.87
Angiogenesis and lymphangiogenesis in stage 1 germ cell tumours of the testis. BJU Int (2000) 0.87
The dormant in vivo phenotype of early stage primary human melanoma: termination by overexpression of vascular endothelial growth factor. Angiogenesis (1998) 0.86
Isolation and properties in culture of human adrenal capillary endothelial cells. Biochem Biophys Res Commun (1991) 0.85
Mid-luteal angiogenesis and function in the primate is dependent on vascular endothelial growth factor. J Endocrinol (2001) 0.85
Application of the enrichment approach to identify putative markers of response to 5-fluorouracil therapy in advanced colorectal carcinomas. Int J Oncol (2000) 0.85
Transcriptional profiling of human microvascular endothelial cells in the proliferative and quiescent state using cDNA arrays. Angiogenesis (1999) 0.84
Urinary basic fibroblast growth factor in patients with bladder cancer and benign prostatic hypertrophy. Br J Urol (1995) 0.84
Overexpression of the angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase in psoriatic epidermis. Br J Dermatol (1997) 0.84
cDNA transfection followed by the isolation of a MCF-7 breast cell line resistant to tamoxifen in vitro and in vivo. Br J Cancer (1993) 0.82
Two mechanisms of basic fibroblast growth factor-induced angiogenesis in bladder cancer. Cancer Res (1997) 0.81
Vascular endothelial growth factor transgenic mice exhibit reduced male fertility and placental rejection. Mol Hum Reprod (2001) 0.81
The stereochemical course of nucleotidyl transfer catalyzed by ATP sulfurylase. J Biol Chem (1982) 0.80
A structure-activity analysis of antagonism of the growth factor and angiogenic activity of basic fibroblast growth factor by suramin and related polyanions. Br J Cancer (1994) 0.80
Expression and mutagenesis of recombinant human and murine erythropoietins in Escherichia coli. Biochim Biophys Acta (1995) 0.80
The isolation, characterization and culture of human decidual endothelium. Hum Reprod (1995) 0.79
Wnt-7a is upregulated by norethisterone in human endometrial epithelial cells: a possible mechanism by which progestogens reduce the risk of estrogen-induced endometrial neoplasia. Cancer Lett (2002) 0.79
Angiogenin depresses aortic smooth muscle cell cAMP by a pertussis toxin sensitive mechanism. Biochem Biophys Res Commun (1989) 0.79
Breast cancer angiogenesis--new approaches to therapy via antiangiogenesis, hypoxic activated drugs, and vascular targeting. Breast Cancer Res Treat (1996) 0.79
Angiogenesis in the endometrium. Angiogenesis (1998) 0.79
Thymidine phosphorylase expression in normal and hyperplastic endometrium. J Clin Pathol (2000) 0.79
Induction of thrombospondin-1 partially mediates the anti-angiogenic activity of dexrazoxane. Br J Cancer (2009) 0.79
Steroids and the endometrium. Curr Med Chem (2000) 0.78
Cell migration and the boyden chamber. Methods Mol Med (2001) 0.78
Protease activated receptor-1 is down regulated by levonorgestrel in endometrial stromal cells. Angiogenesis (2002) 0.78
A spectral study of cobalt(II)-substituted Bacillus cereus phospholipase C. Biochemistry (1986) 0.77
Immunohistochemical properties of the endothelial cells in the human uterus during the menstrual cycle. Hum Reprod (1993) 0.77
Analyzing shoulder translation with navigation technology. Int J Comput Assist Radiol Surg (2012) 0.76
Angiogenesis in breast cancer. Regulation, prognostic aspects, and implications for novel treatment strategies. Ann N Y Acad Sci (1993) 0.76